Pull to refresh
Logo
Daily Brief
Following
Why
Colorectal cancer takes younger lives as public figures sound the alarm

Colorectal cancer takes younger lives as public figures sound the alarm

New Capabilities
By Newzino Staff |

High-profile deaths and celebrity advocacy reshape screening conversation for adults under 50

February 11th, 2026: James Van Der Beek dies at 48

Overview

Colorectal cancer now kills more Americans under 50 than any other cancer. James Van Der Beek, the actor who played Dawson Leery in the defining teen drama of the late 1990s, died February 11 at age 48 after a 30-month battle with the disease—becoming the latest public figure to put a face on an epidemic that medical guidelines have only recently begun to address.

Key Indicators

154,270
Projected U.S. cases in 2025
Colorectal cancer is the third most common cancer diagnosed in both men and women
1 in 5
Diagnoses in adults under 55
Twenty percent of new colorectal cancer cases now occur in people younger than 55
91%
Five-year survival if caught early
When detected at the localized stage before spreading, survival rates are dramatically higher
2.9%
Annual increase in young-adult cases
Incidence rates in people under 50 have risen by nearly 3% per year from 2013 to 2022

Interactive

Exploring all sides of a story is often best achieved with Play.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

Sign Up

Debate Arena

Two rounds, two personas, one winner. You set the crossfire.

People Involved

James Van Der Beek
James Van Der Beek
Actor and colorectal cancer advocate (Died February 11, 2026)
Chadwick Boseman
Chadwick Boseman
Actor (Black Panther) (Died August 28, 2020)
Katie Couric
Katie Couric
Journalist and colorectal cancer advocate (Active advocate)

Organizations Involved

American Cancer Society
American Cancer Society
Nonprofit health organization
Status: Sets screening guidelines

The American Cancer Society in 2018 became the first major organization to lower the recommended colorectal cancer screening age from 50 to 45.

U.S. Preventive Services Task Force (USPSTF)
U.S. Preventive Services Task Force (USPSTF)
Federal advisory panel
Status: Determines insurance coverage requirements

The independent panel whose 2021 recommendation to lower screening age to 45 triggered mandatory insurance coverage under the Affordable Care Act.

Guardant Health
Guardant Health
Biotechnology company
Status: Developed FDA-approved blood screening test

Guardant developed Shield, the first blood test approved by the FDA for colorectal cancer screening, offering an alternative to colonoscopy.

Timeline

  1. James Van Der Beek dies at 48

    Death

    Van Der Beek dies peacefully after weeks in hospice care, survived by his wife Kimberly and six children.

  2. Van Der Beek gives final TODAY interview

    Statement

    The actor describes feeling 'really fortunate in an unfortunate diagnosis' and discusses how cancer taught him he was 'worthy of love.'

  3. Harvard study links ultra-processed foods to cancer precursors

    Research

    Research finds women consuming the most ultra-processed foods had 45% higher risk of developing adenomas, potential precursors to colorectal cancer.

  4. Katie Couric launches 'Lead From Behind' campaign

    Awareness

    On the 25th anniversary of her on-air colonoscopy, Couric partners with Ryan Reynolds' company and the Colorectal Cancer Alliance to destigmatize screening.

  5. Studies show screening guideline change working

    Research

    New research shows early-stage diagnoses in 45-to-49-year-olds jumped 50% after the screening age was lowered, indicating cancers are being caught earlier.

  6. Van Der Beek partners with Guardant Health

    Advocacy

    The actor promotes the Shield blood test as a less invasive alternative to colonoscopy for cancer screening.

  7. Van Der Beek appears on The Real Full Monty

    Awareness

    The actor joins other celebrities on FOX's special, stripping down to raise awareness for prostate, testicular, and colorectal cancer screening.

  8. Van Der Beek publicly reveals cancer diagnosis

    Statement

    More than a year after his diagnosis, Van Der Beek goes public and begins advocating for early screening.

  9. FDA approves Shield blood test for colorectal cancer screening

    Medical Advance

    Guardant Health's Shield becomes the first blood test approved by the FDA as a primary screening option for colorectal cancer.

  10. James Van Der Beek diagnosed with colorectal cancer

    Diagnosis

    The Dawson's Creek star receives a stage 3 diagnosis at age 46. He keeps the diagnosis private for over a year.

  11. USPSTF recommends screening at 45, triggering insurance coverage

    Policy Change

    The federal advisory panel's recommendation means insurers must cover screening without cost-sharing for adults starting at 45.

  12. Chadwick Boseman dies at 43

    Death

    Boseman's death from colon cancer is announced in what becomes the most-liked tweet in Twitter history, driving unprecedented awareness.

  13. American Cancer Society lowers screening age to 45

    Guideline Change

    The ACS becomes the first major organization to recommend screening begin at 45 instead of 50, citing rising incidence in younger adults.

  14. Chadwick Boseman privately diagnosed with colon cancer

    Diagnosis

    The Black Panther star receives a stage 3 diagnosis at age 39 but keeps it private, continuing to work through treatment.

  15. Couric undergoes colonoscopy live on TODAY

    Awareness

    The broadcast is credited with a measurable increase in screening rates, later dubbed the 'Couric Effect.'

  16. Katie Couric's husband dies of colon cancer at 42

    Personal

    Jay Monahan's death from colon cancer sparks Couric's advocacy work and eventually leads to her influential on-air colonoscopy.

Scenarios

1

Screening Rates Reach 80% Target for Adults 45+

Discussed by: American Cancer Society, Colorectal Cancer Alliance, and public health researchers

Sustained celebrity advocacy, improved blood test options like Shield, and mandatory insurance coverage combine to push screening rates toward the 80% goal set by health organizations. Early-stage diagnoses continue rising while late-stage diagnoses and deaths decline. The 'Van Der Beek effect' mirrors the earlier 'Couric Effect,' with his death prompting another measurable surge in screening appointments.

2

Early-Onset Cases Continue Rising Despite Screening Gains

Discussed by: National Cancer Institute researchers, epidemiologists at The Lancet Oncology

While screening catches more cancers earlier, the underlying incidence in young adults continues climbing at 2-3% annually. Research into causes—including ultra-processed foods, microbiome changes, and generational exposures—produces no clear answers. Public health focus shifts from screening alone to prevention, with calls for dietary guidelines and food industry regulation.

3

Blood Tests Replace Colonoscopy as Primary Screening

Discussed by: Guardant Health, gastroenterology journals, healthcare economists

As blood tests like Shield gain acceptance, colonoscopy rates drop while overall screening participation rises. The trade-off—blood tests are less accurate but more likely to be used—proves net positive for population health. Colonoscopy becomes a second-line diagnostic tool rather than first-line screening, fundamentally changing the gastroenterology field.

4

Screening Age Lowered Again to 40

Discussed by: Some oncologists and patient advocacy groups

As young-adult cases continue rising and high-profile deaths accumulate, pressure builds to lower the recommended screening age again. The American Cancer Society and USPSTF convene panels to review evidence. The debate centers on whether the benefits of earlier screening outweigh costs and whether screening alone can address a problem with unclear environmental causes.

Historical Context

The Couric Effect (2000)

March 2000

What Happened

Katie Couric, whose husband had died of colon cancer at 42 two years earlier, underwent a colonoscopy live on the TODAY show. The broadcast reached millions of viewers and was designed to demonstrate that the procedure was safe and manageable.

Outcome

Short Term

Colonoscopy rates increased by 20% in the months following the broadcast, a phenomenon researchers later called the 'Couric Effect.'

Long Term

The broadcast established celebrity health advocacy as a measurable public health tool and launched Couric's decades-long role in colorectal cancer awareness. It demonstrated that visibility and destigmatization could move screening rates.

Why It's Relevant Today

Van Der Beek's advocacy followed the same playbook—using celebrity visibility to normalize screening and share personal experience. His death may produce a similar measurable effect on screening rates.

Chadwick Boseman's Death (2020)

August 2020

What Happened

Boseman died of colon cancer at 43 after keeping his four-year battle private. He had continued working through surgeries and chemotherapy, completing films including Black Panther and Ma Rainey's Black Bottom. His family revealed the diagnosis only upon his death.

Outcome

Short Term

The announcement became the most-liked tweet in history. Internet searches for colon cancer and screening surged. Awareness campaigns specifically targeted the Black community, where Boseman was an icon.

Long Term

Boseman's death accelerated policy changes already underway, providing emotional urgency behind the dry statistics showing rising young-adult cases. His private battle contrasted with later advocates who chose public disclosure.

Why It's Relevant Today

Van Der Beek chose the opposite approach—public disclosure and active advocacy—but both deaths underscore how the disease strikes people in apparent good health with minimal warning signs.

Cervical Cancer Screening and the Pap Test (1940s-1990s)

1941-1996

What Happened

The Pap smear, developed by George Papanicolaou, became widely adopted for cervical cancer screening starting in the 1940s. Over five decades, regular screening became standard care for women, integrated into routine gynecological visits.

Outcome

Short Term

Cervical cancer detection shifted dramatically toward earlier stages.

Long Term

Cervical cancer death rates in the United States dropped by more than 70% between 1955 and 1992, making it one of public health's greatest screening success stories. The key was making screening routine and accessible.

Why It's Relevant Today

Colorectal cancer advocates point to cervical cancer as proof that screening programs can dramatically reduce deaths—if participation rates are high enough. The challenge is making colorectal screening as routine as the Pap smear became.

Sources

(13)